HIGHLIGHTS
- who: Caroline Bailleux from the Department Leon Berard, rue Lau00ebnnec, Lyon, France have published the research work: Treatment strategies for breast cancer brain metastases, in the Journal: (JOURNAL) of 31/05/2020
- what: This study showed that the combination of pertuzumab with trastuzumab and a taxane was superior to the standard trastuzumab plus taxane combination (HR for PFS 0.68, P and amp;lt; 0.001; HR for OS: 0.68, P and amp;lt; 0.001).71 Although the patients reportedly did not have BM at diagnosis, disease relapse occurred in the brain in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.